Histone deacetylase inhibitors and genomic instability.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Cancer Letters

• Publication date

  2009-02-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.canlet.2008.06.005PMID 18635312
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Histone deacetylase inhibitors in lymphoma and solid malignancies

  2008cited by this paper
• Inhibitors of NAD+ dependent histone deacetylases (sirtuins).

  2008cited by this paper
• Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control.

  2008cited by this paper
• Histone deacetylase inhibitors enhance the chemosensitivity of tumor cells with cross‐resistance to a wide range of DNA‐damaging drugs

  2008cited by this paper
• Histone deacetylase inhibitors induce mitotic slippage

  2008cited by this paper
• The Suv39h–HP1 histone methylation pathway is dispensable for enrichment and protection of cohesin at centromeres in mammalian cells

  2008cited by this paper
• Histone deacetylase 3 localizes to the mitotic spindle and is required for kinetochore–microtubule attachment

  2008cited by this paper
• HDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombination

  2007cited by this paper
• Inhibitors of histone deacetylases induce tumor-selective cytotoxicity through modulating Aurora-A kinase

  2007cited by this paper
• The role of chromatin during transcription.

  2007cited by this paper
• Attenuated DNA Damage Repair by Trichostatin A through BRCA1 Suppression

  2007cited by this paper
• Mammalian single-strand break repair: mechanisms and links with chromatin.

  2007cited by this paper
• Histone Deacetylase Inhibitors: Overview and Perspectives

  2007cited by this paper
• Histone deacetylase inhibitors in cancer therapy

  2007cited by this paper
• The spindle-assembly checkpoint in space and time

  2007cited by this paper
• Histone deacetylase inhibitors: molecular mechanisms of action

  2007cited by this paper
• In vivo efficacy of a novel histone deacetylase inhibitor in combination with radiation for the treatment of gliomas.

  2007cited by this paper
• Histone deacetylases and cancer

  2007cited by this paper
• Distinct roles of HDAC complexes in promoter silencing, antisense suppression and DNA damage protection

  2007cited by this paper
• Covalent modifications of histones during development and disease pathogenesis

  2007cited by this paper
• Reversible acetylation of non histone proteins: role in cellular function and disease.

  2007cited by this paper
• Proteome analyses of the growth inhibitory effects of NCH-51, a novel histone deacetylase inhibitor, on lymphoid malignant cells

  2007cited by this paper
• Heterozygous deletion of mitotic arrest-deficient protein 1 (MAD1) increases the incidence of tumors in mice.

  2007cited by this paper
• Histone deacetylase inhibitor NVP-LAQ824 sensitizes human nonsmall cell lung cancer to the cytotoxic effects of ionizing radiation

  2007cited by this paper
• Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation.

  2007cited by this paper
• FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma.

  2007cited by this paper
• Yeast Rtt109 Promotes Genome Stability by Acetylating Histone H3 on Lysine 56

  2007cited by this paper
• Histone deacetylase inhibitors induce premature sister chromatid separation and override the mitotic spindle assembly checkpoint.

  2007influential reference
• Aneuploidy acts both oncogenically and as a tumor suppressor.

  2007cited by this paper
• Aneuploidy: instigator and inhibitor of tumorigenesis.

  2007cited by this paper
• Chromatin modifications and their function.

  2007cited by this paper
• Global chromatin compaction limits the strength of the DNA damage response

  2007cited by this paper
• Intrinsic apoptotic and thioredoxin pathways in human prostate cancer cell response to histone deacetylase inhibitor

  2006cited by this paper
• Histone Deacetylase Inhibitors for Cancer Therapy

  2006cited by this paper
• Cell cycle and checkpoint regulation of histone H3 K56 acetylation by Hst3 and Hst4.

  2006cited by this paper
• Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of γ-H2AX foci

  2006cited by this paper
• Anticancer activities of histone deacetylase inhibitors

  2006cited by this paper
• Mitotic checkpoint slippage in humans occurs via cyclin B destruction in the presence of an active checkpoint.

  2006cited by this paper
• Histone deacetylase (HDAC) inhibitor LBH589 increases duration of gamma-H2AX foci and confines HDAC4 to the cytoplasm in irradiated non-small cell lung cancer.

  2006cited by this paper
• Acetylation of Human 8-Oxoguanine-DNA Glycosylase by p300 and Its Role in 8-Oxoguanine Repair In Vivo

  2006cited by this paper
• Histone deacetylase activity is necessary for chromosome condensation during meiotic maturation in Xenopus laevis

  2006cited by this paper
• Histone deacetylase inhibitors enhance phosphorylation of histone H2AX after ionizing radiation.

  2006cited by this paper
• A novel histone deacetylase pathway regulates mitosis by modulating Aurora B kinase activity.

  2006cited by this paper
• Cotranscriptional processes and their influence on genome stability.

  2006cited by this paper
• The Paradox of Histone Deacetylase Inhibitor-Mediated Modulation of Cellular Responses to Radiation

  2006cited by this paper
• Acetylation and deacetylation of non‐histone proteins

  2006cited by this paper
• Induction of polyploidy by histone deacetylase inhibitor: a pathway for antitumor effects.

  2005cited by this paper
• Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors.

  2005influential reference
• A role for cell-cycle-regulated histone H3 lysine 56 acetylation in the DNA damage response

  2005cited by this paper
• Bub1 and aurora B cooperate to maintain BubR1-mediated inhibition of APC/CCdc20

  2005cited by this paper
• Mitotic spindle checkpoint inactivation by trichostatin A defines a mechanism for increasing cancer cell killing by microtubule-disrupting agents

  2005cited by this paper
• p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.

  2005cited by this paper
• Partial downregulation of MAD1 causes spindle checkpoint inactivation and aneuploidy, but does not confer resistance towards taxol

  2005cited by this paper
• The histone deacetylase inhibitor, trichostatin A, enhances radiation sensitivity and accumulation of gammaH2A.X

  2005cited by this paper
• Regulation of NuA4 Histone Acetyltransferase Activity in Transcription and DNA Repair by Phosphorylation of Histone H4

  2005cited by this paper
• The Sir 2 family of protein deacetylases.

  2005cited by this paper
• The effects of histone deacetylase inhibitors on heterochromatin: implications for anticancer therapy?

  2005influential reference
• Localized Histone Acetylation and Deacetylation Triggered by the Homologous Recombination Pathway of Double-Strand DNA Repair

  2005influential reference
• Acetylation and deacetylation of non-histone proteins.

  2005cited by this paper
• Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid

  2005cited by this paper
• Saccharomyces cerevisiae Sin3p facilitates DNA double-strand break repair.

  2004cited by this paper
• Chromatin dynamics at DNA replication, transcription and repair.

  2004cited by this paper
• Collaboration of homologous recombination and nonhomologous end-joining factors for the survival and integrity of mice and cells.

  2004cited by this paper
• Antitumor histone deacetylase inhibitors suppress cutaneous radiation syndrome: Implications for increasing therapeutic gain in cancer radiotherapy.

  2004cited by this paper
• Cell growth inhibition and gene expression induced by the histone deacetylase inhibitor, trichostatin A, on human hepatoma cells

  2004influential reference
• Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis.

  2004cited by this paper
• Lethality to human cancer cells through massive chromosome loss by inhibition of the mitotic checkpoint.

  2004cited by this paper
• Cell Growth Inhibition and Gene Expression Induced by the Histone Deacetylase Inhibitor, Trichostatin A, on Human Hepatoma Cells

  2004cited by this paper
• Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints.

  2004cited by this paper
• Lysine acetylation and the bromodomain: a new partnership for signaling

  2004cited by this paper
• Complete loss of the tumor suppressor MAD2 causes premature cyclin B degradation and mitotic failure in human somatic cells.

  2004cited by this paper
• Enhancement of Xenograft Tumor Radiosensitivity by the Histone Deacetylase Inhibitor MS-275 and Correlation with Histone Hyperacetylation

  2004cited by this paper
• Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway

  2004cited by this paper
• The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases.

  2004cited by this paper
• Histone deacetylase inhibitors in cancer therapy: is transcription the primary target?

  2003influential reference
• Survivin is required for stable checkpoint activation in taxol-treated HeLa cells

  2003cited by this paper
• Histone Deacetylases: Unique Players in Shaping the Epigenetic Histone Code

  2003cited by this paper
• DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation

  2003cited by this paper
• The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2

  2003cited by this paper
• Endogenous DNA double-strand breaks: Production, fidelity of repair, and induction of cancer

  2003cited by this paper
• Histone hyperacetylation in mitosis prevents sister chromatid separation and produces chromosome segregation defects.

  2003cited by this paper
• Tumor cell‐specific cytotoxicity by targeting cell cycle checkpoints

  2003cited by this paper
• Survivin is required for a sustained spindle checkpoint arrest in response to lack of tension

  2003cited by this paper
• Inhibition of histone deacetylase activity increases chromosomal instability by the aberrant regulation of mitotic checkpoint activation

  2003cited by this paper
• Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines.

  2003influential reference
• The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1.

  2003influential reference
• Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA.

  2003cited by this paper
• Dynamics and diversions in base excision DNA repair of oxidized abasic lesions

  2002cited by this paper
• The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin

  2002cited by this paper
• Recruitment of cohesin to heterochromatic regions by Swi6/HP1 in fission yeast

  2002cited by this paper
• Requirement of Heterochromatin for Cohesion at Centromeres

  2001cited by this paper
• Reversible disruption of pericentric heterochromatin and centromere function by inhibiting deacetylases

  2001cited by this paper
• MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells

  2001cited by this paper
• Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain

  2001influential reference
• The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species

  2001cited by this paper
• Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation.

  2000influential reference
• Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells.

  2000cited by this paper
• Regulation of chromatin structure by site-specific histone H3 methyltransferases

  2000influential reference
• Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins.

  2000cited by this paper
• Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer.

  2000cited by this paper

• Panobinostat Potentiates the Antitumor Efficacy of 5-Fluorouracil in Gastric Cancer by Suppressing Thymidylate Synthase Expression

  2026cites this paper
• Epigenetic targeting of DNA damage response (DDR)-related mechanisms to overcome acquired cisplatin resistance of tumor cells.

  2025cites this paper
• HDAC3 inhibition as a therapeutic strategy in T-cell acute lymphoblastic leukemia via the TYK2-STAT1-BCL2 signaling pathway

  2025cites this paper
• Novel dual inhibitor targeting CDC25 and HDAC for treating triple-negative breast cancer

  2024cites this paper
• Cell Cycle and Senescence Regulation by Podocyte Histone Deacetylase 1 and 2

  2022cites this paper
• Research progress of histone deacetylase inhibitors

  2022cites this paper
• Epigenetics and precision medicine in bone and soft tissue sarcomas

  2022cites this paper
• Chidamide Reverses Fluzoparib Resistance in Triple-Negative Breast Cancer Cells

  2022cites this paper
• T‐17, a novel cyclin‐dependent kinases/histone deacetylases dual inhibitor, induces cancer cells death through cell cycle arrest and apoptosis

  2022cites this paper
• A novel histone deacetylase inhibitor MPT0L184 dysregulates cell-cycle checkpoints and initiates unscheduled mitotic signaling.

  2021cites this paper
• ROS as Regulators of Cellular Processes in Melanoma

  2021cites this paper
• Fluorescent molecular probe-based activity and inhibition monitoring of histone deacetylases.

  2021cites this paper
• Targeting (de)acetylation: A Diversity of Mechanism and Disease

  2021cites this paper
• Oncolytic Bovine Herpesvirus 1 Inhibits Human Lung Adenocarcinoma A549 Cell Proliferation and Tumor Growth by Inducing DNA Damage

  2021cites this paper
• 8a, a New Acridine Antiproliferative and Pro-Apoptotic Agent Targeting HDAC1/DNMT1

  2021cites this paper
• Differential effects of cisplatin combined with the flavonoid apigenin on HepG2, Hep3B, and Huh7 liver cancer cell lines.

  2021cites this paper
• Vorinostat is genotoxic and epigenotoxic in the mouse bone marrow cells at the human equivalent doses.

  2020cites this paper
• Chidamide increases the sensitivity of refractory or relapsed acute myeloid leukemia cells to anthracyclines via regulation of the HDAC3 -AKT-P21-CDK2 signaling pathway

  2020cites this paper
• Discovery of novel cyclin-dependent kinase (CDK) and histone deacetylase (HDAC) dual inhibitors with potent in vitro and in vivo anticancer activity.

  2020cites this paper
• FLT3 inhibition upregulates HDAC8 via FOXO to inactivate p53 and promote maintenance of FLT3-ITD+ acute myeloid leukemia.

  2020cites this paper
• A Chemically Defined Feeder-free System for the Establishment and Maintenance of the Human Naive Pluripotent State

  2019cites this paper
• 6-Methoxyquinoline complexes as lung carcinoma agents: induction of oxidative damage on A549 monolayer and multicellular spheroid model

  2019cites this paper
• Transcriptome and DNA methylation changes modulated by sulforaphane induce cell cycle arrest, apoptosis, DNA damage, and suppression of proliferation in human liver cancer cells.

  2019cites this paper
• Histone deacetylase inhibitor induces DNA damage , which normal but not transformed cells

  2019cites this paper
• Pharmacoepigenetics of Histone Deacetylase Inhibitors in Cancer

  2019cites this paper
• Revisiting Histone Deacetylases in Human Tumorigenesis: The Paradigm of Urothelial Bladder Cancer

  2019cites this paper
• Understanding Apoptosis and Apoptotic Pathways Targeted Cancer Therapeutics

  2019cites this paper
• Magnolol–Coumarin–Phenylbutyric acid Conjugates: An Anticancer Prodrug via multiple targets

  2019cites this paper
• Genotoxic Assays for Measuring P450 Activation of Chemical Mutagens

  2019cites this paper
• Unanchored tri‐NEDD8 inhibits PARP‐1 to protect from oxidative stress‐induced cell death

  2019cites this paper
• Heterocyclic Analogs of Sulforaphane Trigger DNA Damage and Impede DNA Repair in Colon Cancer Cells: Interplay of HATs and HDACs

  2018cites this paper
• Overcoming Resistance to DNA-Targeted Agents by Epigenetic Activation of Schlafen 11 (SLFN11) Expression with Class I Histone Deacetylase Inhibitors

  2018cites this paper
• Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi

  2018cites this paper
• Investigation of belinostat‐induced genomic instability by molecular cytogenetic analysis and pathway‐focused gene expression profiling

  2018cites this paper
• Combinations of Genomically and Immune-Targeted Therapies in Early-Phase Clinical Trials

  2018cites this paper
• Histone deacetylase inhibitors as a new anticancer option : How far can we go with expectations ?

  2018cites this paper
• Rosmarinic Acid, a Component of Rosemary Tea, Induced the Cell Cycle Arrest and Apoptosis through Modulation of HDAC2 Expression in Prostate Cancer Cell Lines

  2018cites this paper
• Rational design and characterization of a DNA/HDAC dual-targeting inhibitor containing nitrogen mustard and 2-aminobenzamide moieties.

  2018cites this paper
• Chromatin dynamics underlying latent responses to xenobiotics.

  2018cites this paper
• Apoptosis signaling and BCL-2 pathways provide opportunities for novel targeted therapeutic strategies in hematologic malignances.

  2017cites this paper
• The Effect of Histone Hyperacetylation on Viability of Basal-Like Breast Cancer Cells MDA-MB-231

  2017cites this paper
• BCL11B-Mediated Epigenetic Repression Is a Crucial Target for Histone Deacetylase Inhibitors in Cutaneous T-Cell Lymphoma.

  2017cites this paper
• Targeting HDAC3, a new partner protein of AKT in the reversal of chemoresistance in acute myeloid leukemia via DNA damage response

  2017cites this paper
• The effects of the HDAC inhibitor sodium butyrate on the expression of repair genes Rad51 and XRCC5 in fibroblast lines mEras-Waf1+/+ and mEras-Waf1–/–

  2017cites this paper
• Histone deacetylase inhibition modulates histone acetylation at gene promoter regions and affects genome-wide gene transcription in Schistosoma mansoni

  2017cites this paper
• Valproic Acid Induces Endocytosis-Mediated Doxorubicin Internalization and Shows Synergistic Cytotoxic Effects in Hepatocellular Carcinoma Cells

  2017cites this paper
• Targeting mitotic pathways for endocrine-related cancer therapeutics.

  2017cites this paper
• Combined therapy of colon carcinomas with an oncolytic adenovirus and valproic acid

  2017cites this paper
• Valproic Acid Induces Endocytosis-Mediated Doxorubicin Internalization and Shows Synergistic Anti-Proliferation Effects in Hepatocellular Carcinoma Cells

  2017cites this paper
• Design, Synthesis, Molecular Modeling, and Biological Evaluation of Novel Amine‐based Histone Deacetylase Inhibitors

  2017cites this paper
• Histone Deacetylase Inhibition Induces Apoptosis and Cell Cycle Dysregulation in Human and Murine Cancer Cell Lines

  2017cites this paper
• Rational design, synthesis and preliminary antitumor activity evaluation of a chlorambucil derivative with potent DNA/HDAC dual-targeting inhibitory activity.

  2017cites this paper
• Suberanilohydroxamic acid (vorinostat) synergistically enhances the cytotoxicity of doxorubicin and cisplatin in osteosarcoma cell lines

  2016cites this paper
• Extrachromosomal HPV-16 LCR transcriptional activation by HDACi opposed by cellular differentiation and DNA integration

  2016cites this paper
• An overview of investigational Histone deacetylase inhibitors (HDACis) for the treatment of non-Hodgkin’s lymphoma

  2016cites this paper
• The Effect of HDAC Inhibitor MI192 on Stem Cell Behaviour-The Potential of Utilising MI192 for Bone Tissue Engineering

  2016cites this paper
• Down‐Regulation of Thioredoxin1 Is Involved in Death of Calu‐6 Lung Cancer Cells Treated With Suberoyl Bishydroxamic Acid

  2016cites this paper
• Effect of Butyric Acid on p53 Expression and Apoptosis in Colon Epithelial Cells in Mice after Treated with 9,10-dimethyl-1,2-benz(a)anthracene

  2016cites this paper
• Cytotoxic effects of peanut phenolics possessing histone deacetylase inhibitory activity in breast and cervical cancer cell lines

  2016cites this paper
• Identification of neutrophil-derived proteases and angiotensin II as biomarkers of cancer cachexia

  2016cites this paper
• Panobinostat induces apoptosis via production of reactive oxygen species and synergizes with topoisomerase inhibitors in cervical cancer cells.

  2016cites this paper
• Inhibition of histone deacetylases in cancer therapy: lessons from leukaemia

  2016cites this paper
• Potential of apoptotic pathway-targeted cancer therapeutic research: Where do we stand?

  2016cites this paper
• Common SAR Derived from Multiple QSAR Models on Vorinostat Derivatives Targeting HDACs in Tumor Treatment.

  2016cites this paper
• Histone deacetylase inhibitors and epigenetic regulation in lymphoid malignancies

  2015cites this paper
• Anticancer potential of the histone deacetylase inhibitor-like effects of flavones, a subclass of polyphenolic compounds: a review

  2015cites this paper
• Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells

  2015cites this paper
• Iron complexation to histone deacetylase inhibitors SAHA and LAQ824 in PEGylated liposomes can considerably improve pharmacokinetics in rats.

  2015cites this paper
• Targeting post-translational modifications of histones for cancer therapy.

  2015cites this paper
• Oxidative stress, redox regulation and diseases of cellular differentiation.

  2015cites this paper
• Oxidative stress diverts tRNA synthetase to nucleus for protection against DNA damage.

  2014cites this paper
• Multiple mechanisms contribute to the synergistic anti-myeloma activity of the pan-histone deacetylase inhibitor LBH589 and the rapalog RAD001.

  2014cites this paper
• Modulation of Clr-b Ligand for the Inhibitory NKR-P1B NK Cell Receptor in Response to Transformation and Genotoxic Stress

  2014cites this paper
• The role of acetylation in the regulation of antimicrobial peptide gene expression in the human intestine

  2014cites this paper
• Inhibiting protein clearance to induce cell death in tuberous sclerosis and pancreatic cancer

  2014influential citation
• Suberoylanilide hydroxamic acid-induced HeLa cell death is closely correlated with oxidative stress and thioredoxin 1 levels.

  2014cites this paper
• New and emerging HDAC inhibitors for cancer treatment.

  2014cites this paper
• Salt-inducible kinase 3 is a novel mitotic regulator and a target for enhancing antimitotic therapeutic-mediated cell death

  2014cites this paper
• The Therapeutic Potential of Class I Selective Histone Deacetylase Inhibitors in Ovarian Cancer

  2014cites this paper
• Caspase-3 and Caspase-6 cleave STAT1 in leukemic cells

  2014cites this paper
• SAHA, histone deacetylase inhibitor causes reduction of aflatoxin production and conidiation in the Aspergillus flavus

  2013cites this paper
• Histone deacetylase inhibitor Trichostatin A induces neural tube defects and promotes neural crest specification in the chicken neural tube.

  2013cites this paper
• Peptide based macrocycles: selective histone deacetylase inhibitors with antiproliferative activity.

  2013cites this paper
• Three-dimensional quantitative analysis of chromosomes in the oocytes of aging mice during meiosis I in vitro.

  2013cites this paper
• Valproic acid inhibits the growth of HeLa cervical cancer cells via caspase-dependent apoptosis.

  2013cites this paper
• The methylation landscape of tumour metastasis

  2013cites this paper
• Plant Polyphenols and Oxidative Metabolites of the Herbal Alkenylbenzene Methyleugenol Suppress Histone Deacetylase Activity in Human Colon Carcinoma Cells

  2013cites this paper
• Mitosis as an anti-cancer drug target

  2013cites this paper
• Trichostatin A induces apoptotic cell death of HeLa cells in a Bcl-2 and oxidative stress-dependent manner.

  2013cites this paper
• Unexplored Potentials of Epigenetic Mechanisms of Plants and Animals—Theoretical Considerations

  2013cites this paper
• HDAC turnover, CtIP acetylation and dysregulated DNA damage signaling in colon cancer cells treated with sulforaphane and related dietary isothiocyanates

  2013cites this paper
• Histone Deacetylase Regulation of ATM-Mediated DNA Damage Signaling

  2013cites this paper
• A dual role for Hdac1: oncosuppressor in tumorigenesis, oncogene in tumor maintenance.

  2013cites this paper
• A model of sensitivity and resistance to histone deacetylase inhibitors in diffuse large B cell lymphoma

  2013cites this paper
• Protective roles of epithelial cells in the survival of adult T-cell leukemia/lymphoma cells.

  2013cites this paper
• Evaluating the genotoxicity of topoisomerase-targeted antibiotics.

  2012cites this paper
• Sensitization of tumor cells by targeting histone deacetylases.

  2012cites this paper
• Valproic acid for the treatment of malignant gliomas: review of the preclinical rationale and published clinical results

  2012influential citation
• HDAC inhibitors: roles of DNA damage and repair.

  2012cites this paper
• The spindle assembly checkpoint as a drug target - Novel small-molecule inhibitors of Aurora kinases

  2012cites this paper